Form 4 for TXN Texas Instruments
Accepted 2022-02-08 00:00:00 ET · period of report 2022-02-04 · accession 0001127602-22-003783 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-08 | 2022-02-04 | TXN | BLINN MARK A | Dir | M - OptEx | $114.36 | +3,188 | 16.3K | +24% | +$364.6K |
| DM | 2022-02-08 | 2022-02-04 | TXN | BLINN MARK A | Dir | S - Sale+OE | $170.54 | -4,095 | 15.8K | -21% | -$698.4K |
| DM | 2022-02-08 | 2022-02-04 | TXN | BLINN MARK A | Dir | M - OptEx | $0.00 | -3,188 | 1,956 | -62% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-04 | M | A | 1,077 | $110.15 | 14,140 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-04 | M | A | 1,133 | $104.41 | 15,273 | D | — | — | |
| 3 | Common | Common Stock | 2022-02-04 | M | A | 978 | $130.52 | 16,251 | D | — | — | |
| 4 | Common | Common Stock | 2022-02-04 | S | D | 501 | $172.32 | 12,156 | D | — | — | (F5) The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $172.055 to $172.68. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. |
| 5 | Common | Common Stock | 2022-02-04 | S | D | 845 | $169.19 | 14,942 | D | — | — | (F2) The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $168.775 to $169.69. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. |
| 6 | Common | Common Stock | 2022-02-04 | S | D | 635 | $170.44 | 14,307 | D | — | — | (F3) The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $169.985 to $170.915. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. |
| 7 | Common | Common Stock | 2022-02-04 | S | D | 1,650 | $171.40 | 12,657 | D | — | — | (F4) The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $171.01 to $171.89. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. |
| 8 | Common | Common Stock | 2022-02-04 | S | D | 464 | $168.16 | 15,787 | D | — | — | (F1) The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $167.65 to $168.48. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. |
| 9 | Derivative | NQ Stock Option (Right to Buy) | 2022-02-04 | M | D | 1,077 | $0.00 | 0 | D | $110.15 · — to 2028-01-25 | 1,077 Common Stock | (F10) The option became exercisable in four equal annual installments beginning on January 25, 2019. |
| 10 | Derivative | NQ Stock Option (Right to Buy) | 2022-02-04 | M | D | 1,133 | $0.00 | 1,133 | D | $104.41 · — to 2029-01-25 | 1,133 Common Stock | (F11) The option became exercisable in four equal annual installments beginning on January 25, 2020. |
| 11 | Derivative | NQ Stock Option (Right to Buy) | 2022-02-04 | M | D | 978 | $0.00 | 1,956 | D | $130.52 · — to 2030-01-24 | 978 Common Stock | (F12) The option became exercisable in four equal annual installments beginning on January 24, 2021. |